Norwegian version of this page

News

Published June 3, 2021 1:50 PM

Recently the new biotech company Tribune Therapeutics was established based on research conducted by Ole Jørgen Kaasbøll and Håvard Attramadal. Ole Jørgen Kaasbøll was admitted to UiO:Life Science’ innovation programme SPARK Norway in 2019 and will now assume the role of Chief Scientific Officer in the new company where Georg Vo Beiske, HealthCap has been appointed Chief Executive Officer. Tribune Therapeutics aims to develop a treatment for fibrosis.

Published May 19, 2021 1:13 PM

An updated suite of viral vectors for in vivo calcium imaging using local and retro-orbital injections

We show that systemic injections of PHP.eB AAVs to express GECIs is a highly promising technique for imaging neural activity and circumvent the need for transgenic GECI expressing mouse lines. We also establish the use of novel soma-targeted GECIs that outperform current Ca2+ indicators using both systemic and local virus injections.